WallStreetZenWallStreetZen

NASDAQ: MIRM
Mirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Mirum Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Saira RamasastryDirector2026-02-132,000$23.51
$47.02kBuy
Saira RamasastryDirector2026-02-132,000$102.09
$204.18kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-02-029,108$103.30
$940.88kSell
Jolanda HoweSVP GLOBAL CONTROLLER2026-02-02968$103.30
$100.00kSell
Peter RadovichPRESIDENT AND COO2026-02-022,631$103.30
$271.79kSell
Jolanda HoweSVP GLOBAL CONTROLLER2026-01-26842$96.19
$80.99kSell
Peter RadovichPRESIDENT AND COO2026-01-263,143$96.19
$302.33kSell
Eric BjerkholtCHIEF FINANCIAL OFFICER2026-01-261,053$96.19
$101.29kSell
Christopher PeetzCHIEF EXECUTIVE OFFICER2026-01-266,831$96.19
$657.09kSell
Patrick J. HeronDirector2026-01-23131,425$68.48
$9.00MBuy

1 of 7

MIRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MIRM insiders and whales buy or sell their stock.

MIRM Shareholders

What type of owners hold Mirum Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Frazier Life Sciences Management LP11.26%6,795,121$596.61MInstitution
Janus Henderson Group PLC10.05%6,065,308$532.53MInstitution
David M. Mott6.94%4,186,243$367.55MInsider
Peter J. Barris6.94%4,186,243$367.55MInsider
Peter W. Sonsini6.94%4,186,243$367.55MInsider
Joshua Makower6.94%4,186,243$367.55MInsider
Patrick J. Heron6.68%4,031,625$353.98MInsider
Blackrock Inc6.04%3,645,286$320.06MInstitution
Frazier Life Sciences IX LP5.91%3,566,912$313.17MInsider
James E. Flynn5.38%3,244,434$284.86MInsider

1 of 3

MIRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MIRM53.76%46.24%Net BuyingNet Buying
BLTE22.59%0.00%
IMVT47.79%52.21%Net BuyingNet Buying
CRSP68.98%31.02%Net BuyingNet Selling
SRRK60.19%39.81%Net BuyingNet Buying
View Top Biotech Stocks

Mirum Pharmaceuticals Stock Ownership FAQ

Who owns Mirum Pharmaceuticals?

Mirum Pharmaceuticals (NASDAQ: MIRM) is owned by 101.13% institutional shareholders, 86.99% Mirum Pharmaceuticals insiders, and 0.00% retail investors. David M. Mott is the largest individual Mirum Pharmaceuticals shareholder, owning 4.19M shares representing 6.94% of the company. David M. Mott's Mirum Pharmaceuticals shares are currently valued at $389.49M.

If you're new to stock investing, here's how to buy Mirum Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.